Formycon AG (CHIX:FYBD) Total Liabilities: €340.39 Mil (As of Dec. 2025)


CHIX:FYBD Formycon AG CHIX:FYBD
56 GF Score
Price €63.30
GF Value €120.94
! 5 Warning Signs
View Full Analysis

What is Formycon AG Total Liabilities?

Formycon AG CHIX:FYBD 56 Total Liabilities is €340.39 Mil as of Dec. 2025. GuruFocus rates CHIX:FYBD with a GF Score™ of 56/100 and a GF Value™ of €120.94. The stock has 5 warning signs investors should review.

Formycon AG's Total Liabilities for the quarter that ended in Dec. 2025 was €340.39 Mil.

Formycon AG's quarterly Total Liabilities increased from Dec. 2024 (€309.87 Mil) to Jun. 2025 (€334.23 Mil) and increased from Jun. 2025 (€334.23 Mil) to Dec. 2025 (€340.39 Mil).

Formycon AG's annual Total Liabilities declined from Dec. 2023 (€387.61 Mil) to Dec. 2024 (€309.87 Mil) but then increased from Dec. 2024 (€309.87 Mil) to Dec. 2025 (€340.39 Mil).

Formycon AG Total Liabilities Historical Data

* Premium members only.

The historical data trend for Formycon AG's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Formycon AG Total Liabilities Chart

Formycon AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.82 497.12 387.61 309.87 340.39

Formycon AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 387.61 371.48 309.87 334.23 340.39
CHIX:FYBD
56GF Score
Formycon AG CHIX:FYBD
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Formycon AG Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Formycon AG's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=53.56+(8.082+278.749
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=340.39

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=739.527-399.136
=340.39

Formycon AG's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=53.56+(8.082+278.749
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=340.39

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=739.527-399.136
=340.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €340.39 Mil mean?
Formycon AG (CHIX:FYBD) has a Total Liabilities of €340.39 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Formycon AG and its competitors.
Is Formycon AG's Total Liabilities too high?
Formycon AG's current Total Liabilities is €340.39 Mil. Overall, Formycon AG has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Formycon AG's Total Liabilities compare to VRTX and REGN?
Formycon AG's Total Liabilities of €340.39 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Formycon AG and its competitors. Formycon AG's current Total Liabilities is €340.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Formycon AG stock overvalued right now?
Formycon AG (CHIX:FYBD) has a current Total Liabilities of €340.39 Mil. The stock's GF Value™ is €120.94, compared to a current price of €63.30 — trading 47.7% below its estimated fair value. The current Total Liabilities is €340.39 Mil. Formycon AG's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Formycon AG (CHIX:FYBD), the current Total Liabilities is €340.39 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Formycon AG (CHIX:FYBD) Overvalued in 2026?

Based on GuruFocus' analysis, Formycon AG stock appears to be undervalued. The current stock price of €63.30 is trading 47.7% below its estimated GF Value™ of €120.94.

Key valuation signals for CHIX:FYBD:

  • Total Liabilities: €340.39 Mil
  • GF Value™: €120.94 vs. price of €63.30 (47.7% below fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the CHIX:FYBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Formycon AG Business Description

Address Fraunhoferstrasse 15, Martinsried, Planegg, BY, DEU, 82152
Formycon AG is an independent developer of high-quality biosimilars, which are follow-on products to biopharmaceutical drugs. The Company focuses on expanding and further developing its scalable biosimilar platform, which includes approved and pipeline products across ophthalmology, immunology, and immuno-oncology. Its key products include FYB201 (ranibizumab), FYB202 (ustekinumab), FYB203 (aflibercept), FYB206 (pembrolizumab), and FYB208 (dupilumab), along with additional biosimilar candidates in various stages of development. The Company generates maximum revenue from Switzerland.
56GF Score

Get the complete analysis for CHIX:FYBD

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€63.30
Price
€120.94
GF Value